RFI SOW Electronic Prescribing.docx

Department of State 19AQMM26XXXXX Request for Information

Statement of Work (SOW) Request for Information Bureau of Medical Services Electronic Prescribing of Controlled Substances (EPCS) Solution

1. Introduction The Bureau of Medical Services (MED) is seeking information from qualified technology providers regarding solutions for electronic prescribing, including the electronic prescribing of controlled substances (EPCS). The Department is interested in solutions that enhance patient safety, streamline provider workflows, and ensure compliance with all applicable federal and state regulations. The solution must be capable of integrating with the Department’s existing electronic medical system.

2. Purpose This RFI is issued solely for information and planning purposes. It does not constitute a solicitation or a promise to issue a solicitation in the future. Responses to this RFI will assist the Department in understanding available technologies, industry capabilities, and best practices for implementing an electronic prescribing solution that meets the Department’s needs.

3. Desired Capabilities Respondents are requested to provide information on solutions that address the following requirements:

A. Electronic Prescribing (eRx) Functionality

· Ability for providers to electronically create, modify, renew, cancel and transmit prescriptions to U.S based pharmacies.

· Support for medication history, drug-allergy checks, and drug-drug interaction alerts.

· Access to formulary and benefit information at the point of care.

· Comprehensive external medication history import

· Structured medication list reconciliation

· Refill and renewal management workflows

· Cancel, change, and discontinue prescription messaging

B. Electronic Prescribing of Controlled Substances (EPCS)

· Compliance with all federal and state regulations, including DEA requirements for EPCS.

· Integrated Dosage calculator

· Implementation of two-factor authentication and identity proofing for prescribers.

· Secure audit trails and comprehensive reporting for all controlled substance prescriptions.

· Integrated Prescription Drug Monitoring Program (PDMP) query within prescribing workflow

· Automated PDMP checks where required

· Display of recent controlled substance fill history

· Audit logging of PDMP access

· Compliance with federal and state EPCS requirements

C. Integration

· Capability to integrate with the Department’s electronic medical system using industry-standard protocols (e.g., HL7, FHIR, APIs).

· Support for single sign-on (SSO) and user role management in accordance with Department IT security policies.

· Real-time data exchange for patient demographics, medication lists, pharmacy lists, and prescription status.

· The solution shall support EHR-initiated eRx prescribing workflows, enabling authorized providers to perform functions listed in Section A.

D. Security and Compliance

· Adherence to HIPAA, HITECH, and all relevant privacy and security regulations.

· Robust data encryption in transit and at rest.

· Maintenance of comprehensive audit logs and support for compliance reporting.

E. User Experience and Support

· Intuitive, user-friendly interface for prescribers and support staff.

· Availability of training materials and user support during and after implementation.

· System availability and technical support in line with industry best practices.

· Embedded prescribing UI

· Minimal-click medication search and selection

· Context-aware default dosing

· Mobile and remote prescribing capability

· Dashboard for pending renewals and prescribing tasks

· Ability to assign multiple locations to providers

· Staff/support account flexibility

· Third-Party Escalation Support

F. Implementation and Maintenance

· Approach to system configuration, data migration, and user training.

· Testing and validation processes prior to go-live.

G. Clinical Safety & Decision Support

· Real-time drug–drug interaction checking

· Drug–allergy interaction checking

· Drug–disease contraindication checking

· Duplicate therapy detection

· Dose range checking (age, weight, renal/hepatic function aware)

· Clinical decision support alerts with configurable severity levels

· Evidence-based prescribing guidance

· Controlled substance risk alerts

F. Reporting

· Prescribing activity dashboards

· Antimicrobial stewardship reporting capability

· Quality metric reporting (where applicable)

· Exportable structured data for analytics

4. Response Instructions Interested parties are requested to submit a written response that includes the following:

· A brief overview of the company and relevant experience with electronic prescribing solutions.

· A description of the proposed solution and how it meets the desired capabilities outlined above.

· Information on integration experience with electronic medical systems, including supported protocols and security features.

· Details on implementation approach, training, and support services.

· Case studies or references from similar projects, if available.

· Estimated timelines for implementation and transition.

· Any additional information, recommendations, or innovative features that may benefit the Department.

5. Submission Details Responses should be submitted electronically in PDF format to the contracting officer Alicia Hofhine, HofhineAK@state.gov by Friday, April 10, 2026. Questions regarding this RFI may be directed to Alicia Hofhine, HofhineAK@state.gov.

6. Disclaimer This RFI is for informational purposes only and does not obligate the Department to issue a solicitation or award a contract. The Department will not reimburse respondents for any costs incurred in preparing or submitting a response to this RFI.

Source Selection Information – See FAR 2.101 and 3.104